Pacific Biosciences Powers SARS-CoV-2 Research at Commercial, Academic and Government Labs April 8, 2020April 8, 2020 by / Share This.....LinkedinTwitterFacebookGoogleEmailLabCorp, UC San Diego and the National Institute of Allergy and Infectious Diseases are among the organizations utilizing PacBio’s highly accurate long-read sequencing technology to study SARS-CoV-2 and the related immune response to COVID-19 Related News: Bruker Advances Magnet Technology for Broader…True Mass presents first commercial CDMS instrument…Unchained Labs blasts Big Kahuna and Junior into the…Clear Labs Automated NGS Technology Platform (Clear…PerkinElmer Streamlines Flow Cytometry Management…Unchained Labs likes it hot, launches new isothermal…
